Ligand Pharmaceuticals | LGND

Ligand Pharmaceuticals traded at $72.11 this Wednesday March 29th, decreasing $1.52 or 2.06 percent since the previous trading session. Looking back, over the last four weeks, Ligand Pharmaceuticals lost 2.45 percent. Over the last 12 months, its price fell by 37.93 percent. Looking ahead, we forecast Ligand Pharmaceuticals to be priced at 67.17 by the end of this quarter and at 60.97 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Acorda Therapeutics 0.60 0.02 2.62% -64.29%
Agenus 1.56 0.08 5.41% -40.46%
Amgen 241.03 2.55 1.07% -0.63%
Anika Therapeutics 28.54 0.42 1.49% 13.12%
Arrowhead Research 24.74 0.48 1.98% -45.73%
Baxter International 40.54 0.69 1.73% -48.93%
Bristol-Myers Squibb 68.18 -0.02 -0.03% -7.51%
Clovis Oncology 0.10 0.001 1.00% -93.88%
Endo International 0.08 0.01 7.91% -96.69%
Enanta Pharmaceuticals 40.27 1.45 3.74% -41.82%
Gilead Sciences 81.29 0.32 0.40% 36.74%
GlaxoSmithKline 1,420.60 -0.40 -0.03% -14.46%
Glaxosmithkline 35.06 -0.04 -0.11% -19.77%
Heron Therapeutics 1.69 0.08 4.97% -70.30%
Harsco 6.61 0.07 1.07% -45.55%
Immunogen 3.83 0.14 3.79% -19.37%
Insmed 17.14 0.34 2.02% -25.22%
Ionis Pharmaceuticals 35.48 1.19 3.47% -0.59%
Karyopharm Therapeutics 3.92 0.41 11.68% -46.67%
Lannett 1.56 0 0% 90.04%
Ligand Pharmaceuticals 72.11 -1.52 -2.06% -37.93%
Eli Lilly 335.87 -1.78 -0.53% 15.86%
MacroGenics 7.24 0.59 8.87% -18.28%
Merck & Co 104.92 -0.61 -0.58% 27.33%
Pacira 40.77 0.86 2.15% -46.12%
Pfizer 40.25 0.26 0.65% -22.25%
Rigel Pharmaceuticals 1.42 0.06 4.41% -52.82%
Sangamo BioSciences 1.76 0.06 3.53% -70.32%
Spectrum Pharmaceuticals 0.71 0.04 5.97% -43.65%
Teva Pharmaceutical Industries 8.84 0.08 0.91% -5.76%
Veracyte 21.47 0.89 4.32% -25.35%
Intrexon 1.02 0.14 15.44% -51.66%

Indexes Price Day Year
USND 11926 210.16 1.79% -17.42%
US400 2462 28.65 1.18% -9.89%

Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.